Shares of Max Healthcare Institute Ltd climbed as much as 6 percent on Thursday after global brokerage Citi initiated coverage on the hospital operator with a ‘Buy’ rating and a target price of Rs 1,240 per share.
With a market capitalization of around Rs 1.05 lakh crore, the stock touched an intraday high of Rs 1,088, compared with its previous close of Rs 1,026.15. Over the last five years, the stock has delivered returns of about 331 percent.
Citi Sees 21% Upside
Citi’s target price implies an upside potential of around 21 percent from the previous closing level.
The brokerage expects EBITDA to grow at a compound annual rate of 20 percent between FY26 and FY30, supported by steady demand, operating leverage and expansion plans.
It also projects:
- Revenue growth of around 15 percent in FY27.
- Further acceleration in growth during FY28.
- Strong earnings visibility over the medium term.
However, Citi said delays in project execution remain a key risk.
Valuations Improve After Correction
According to the brokerage, the stock has corrected around 18 percent from its 52-week high, bringing valuations closer to historical averages.
The recent decline has improved the risk-reward profile and made the stock more attractive from a medium-term perspective.
Trading Volumes Spike
Investor activity in the stock surged sharply during the session.
Trading volumes rose from an hourly average of nearly 277,000 shares to around 1.4 million shares, representing an increase of about 394 percent.
The stock also crossed its average daily volume of 3.75 million shares, with nearly 5 million shares changing hands during the first four hours of trading.
Technical Indicators Remain Positive
From a technical standpoint, Max Healthcare continued to trade above key moving averages, including:
- 50-day EMA
- 200-day EMA
The positioning above these levels indicates that the broader uptrend remains intact.
Capacity Expansion To Drive Growth
Max Healthcare is pursuing growth through both operational improvements and capacity additions.
Existing network optimisation
The company is focusing on:
- Better specialty mix
- Higher occupancy and utilization
- Improved operational efficiency
- Stronger payor mix
These initiatives are aimed at improving returns without significant incremental capital expenditure.
Expansion plans
The hospital chain is adding capacity through multiple routes:
- Around 2,000 beds through brownfield projects
- Asset-light O&M and lease models
- Strategic acquisitions
- Greenfield hospitals in high-growth markets such as Gurgaon and Lucknow
These initiatives are expected to nearly double capacity over the medium term.
Strong balance sheet supports expansion
As of FY26, the company reported:
- Operating cash flow: Rs 1,541 crore
- Net debt: Rs 1,908 crore
- ROCE: Around 23 percent
The healthy financial position gives the company flexibility to pursue expansion while maintaining balance sheet strength.
Q4 FY26 Performance
For the March quarter, Max Healthcare reported:
| Particulars | Q4 FY26 | Q4 FY25 | Growth |
|---|---|---|---|
| Revenue | Rs 2,143 crore | Rs 1,910 crore | 12% |
| EBITDA | Rs 606 crore | Rs 512 crore | 19% |
| Net Profit | Rs 342 crore | Rs 319 crore | 7% |
| EPS | Rs 3.52 | Rs 3.28 | 7% |
About the Company
Max Healthcare Institute Ltd is one of India’s largest private hospital operators.
The company runs:
- Multi-specialty hospitals
- Super-specialty hospitals
- Medical centres
- Primary care clinics
It operates more than 22 facilities with over 5,000 beds, mainly across North and West India.
TL;DR
Max Healthcare shares gained 6 percent after Citi initiated coverage with a ‘Buy’ rating and a target price of Rs 1,240. The brokerage expects 20 percent EBITDA CAGR through FY30, while capacity expansion and strong cash generation are expected to support growth.
AI Summary
- Max Healthcare shares rose 6 percent on Thursday.
- Citi initiated coverage with a Buy rating and Rs 1,240 target.
- Brokerage expects 20% EBITDA CAGR between FY26 and FY30.
- Trading volumes surged nearly 394 percent.
- Expansion plans include around 2,000 additional beds.